Showing results (661-670 of 4,634) with videos related to

Sort By:
Pageof 464
Anti-Cancer Drugs|October 19, 2000
The clinical pharmacology of alkylating agents in high-dose chemotherapyA D Huitema, K D Smits, R A Mathôt, et al.
Anti-Cancer Drugs|October 19, 2000
Phase II study of bendamustine in patients with relapsed or cisplatin-refractory germ cell cancerC Kollmannsberger, A Gerl, N Schleucher, et al.
Anti-Cancer Drugs|October 19, 2000
Dose-finding study of paclitaxel and carboplatin in patients with advanced non-small cell lung cancerJ F Morère, S Piperno-Neumann, M A Coulon, et al.
Anti-Cancer Drugs|June 8, 2001
Pharmacokinetics of paclitaxel and cisplatin in a hemodialysis patient with recurrent ovarian cancerM Tomita, H Kurata, Y Aoki, et al.
Anti-Cancer Drugs|December 10, 2019
Induction treatment prior to chemoradiotherapy in nasopharyngeal carcinoma: triplet or doublet chemotherapy?Maeve A Hennessy, Patrick G Morris
Anti-Cancer Drugs|March 19, 2020
Modulation of oxidative stress/antioxidative defence in human serum treated by four different tyrosine kinase inhibitorsMarija Mihajlovic, Branka Ivkovic, Biljana Jancic-Stojanovic, et al.
Anti-Cancer Drugs|February 29, 2020
Outcomes in hepatocellular carcinoma patients undergoing sorafenib treatment: toxicities, cellular oxidative stress, treatment adherence, and quality of lifeGraziele Baldan Ferrari, Júlia Coelho França Quintanilha, Marília Berlofa Visacri, et al.
Anti-Cancer Drugs|December 12, 2018
Design, synthesis, and biological evaluation of tetrahydroisoquinoline-based diaryl urea derivatives for suppressing VEGFR-2 signalingYuanzheng Huang, Yang Zhang, Jiaming Li, et al.
Anti-Cancer Drugs|November 26, 2019
Antitumor activity of a hydrogel loaded with lipophilic bismuth nanoparticles on cervical, prostate, and colon human cancer cellsClaudio Cabral-Romero, Juan M Solís-Soto, Yesennia Sánchez-Pérez, et al.
Anti-Cancer Drugs|December 3, 2019
Quantitative proteomic analysis reveals that Luks-PV exerts antitumor activity by regulating the key proteins and metabolic pathways in HepG2 cellsChang-Cheng Zhao, Wen-Wei Yu, Ying-Jie Qi, et al.
Pageof 464